Company: RPTX
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001193125-25-283336
Chunk: 0

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 0
---
Repare Therapeutics Inc.

Condensed Consolidated Balance Sheets 

(Unaudited) 

(Amounts in thousands of U.S. dollars, except share data) 

     As of September 30,

     As of December 31,

     2025

     2024

     ASSETS

     CURRENT ASSETS:

     Cash and cash equivalents
      
     $
     72,825

     $
     84,717

     Marketable securities

     39,779

     68,074

     Income tax receivable

     1,802

     10,600

     Other current receivables

     6,487

     1,746

     Prepaid expenses

     3,533

     6,012

     Total current assets

     124,426

     171,149

     Property and equipment, net

     —

     2,294

     Operating lease right-of-use assets

     —

     1,924

     Income tax receivable

     —

     960

     Investment in equity securities

     1,721

     —

     Other assets

     600

     179

     TOTAL ASSETS
      
     $
     126,747

     $
     176,506

     LIABILITIES AND SHAREHOLDERS’ EQUITY

     CURRENT LIABILITIES:

     Accounts payable
      
     $
     1,334

     $
     3,623

     Accrued expenses and other current liabilities

     9,944

     19,819

     Operating lease liability, current portion

     342

     1,845

     Total current liabilities

     11,620

     25,287

     Operating lease liability, net of current portion

     —

     88

     TOTAL LIABILITIES

     11,620

     25,375

     SHAREHOLDERS’ EQUITY

     Preferred shares, no par value per share; unlimited shares authorized as of   September 30, 2025 and December 31, 2024; 0 shares issued and outstanding   as of September 30, 2025, and December 31, 2024

     —

     —

     Common shares, no par value per share; unlimited shares authorized as of    September 30, 2025 and December 31,